Welcome Center  |   Log In  |   Register  |   Follow Us  Facebook  Twitter Google Plus

Latest in Allergy & Clinical Immunology

Epstein-Barr virus (EBV), similar to other common viruses, remains in the body indefinitely after exposure and requires constant monitoring by the immune system in order to effectively to restrain it. Patients who have had a bone marrow transplant are...
TXA-709 is a new type of antibiotic being developed by TAXIS Pharmaceuticals. The antibiotic specifically targets variants of the MRSA bacteria. TXA-709, a FtsZ-targeting benzamide prodrug, should be able to circumvent the problem of antibiotic resistance...
The unique pharmacokinetic properties of TXA-709 may allow it to effectively treat staphylococcus aureus infections, including MRSA, while reducing the possibility of patients developing a resistance to the antibiotic. Animal model studies have shown that...